Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avivagen Inc V.VIV.H

Alternate Symbol(s):  VIVXF

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.


TSXV:VIV.H - Post by User

Post by StoneMan45on Apr 23, 2021 9:11am
222 Views
Post# 33054129

NCNB ...at least link it to OxC beta

NCNB ...at least link it to OxC betaOxC beta should be receiving more attention as a full spectrum product that can help to address Covid-19 and furure virus or disease issues. The combined benefits of OxC-beta on any animals body in relatively low concentrations and that these benifits are a healthy proactive measure with benefits to healthy individuals as well as more pronounced benefits to those that have gut/digestive issues, inflamitory issues etc etc , should drive OxC Beta sales for human use. Issue I see here is that Dr. Tobias has labelled the human-use form as 50 mg of Beta-Carotene Norisoprenoid Blend (BCNB) 
beta carotene, supplements, immune, support, supplement, immunity, vitamins, vitamin A, Dr. Tobias
beta carotene, supplements, immune, support, supplement, immunity, vitamins, vitamin A, Dr. Tobias

There needs to be continuity and clarity so labelling  OxC Beta as NCNB makes little sense as it excludes info that should be available to potential users of this product ...they need to address this.

Avivagen's discovery, OxC-Beta, is an immune primer. In all animals, including humans, it elevates and multiplies the sensors in the body to react to foreign invaders much more quickly than usual.  That means any immuno-compromised person or animal can benefit from OxC-Beta's powerful action.                           
 also...  OxC-Beta works to reduce inflammation in both humans and animals.  Most illnesses are caused by chronic inflammation or by the body's immune response generating an inflammatory response.  OxC-Beta works to help both scenarios, naturally.  It's the future of healthcare.
<< Previous
Bullboard Posts
Next >>